Author

Zhaoxing Wu

Second Affiliated Hospital of Zhejiang UniversityORCID 0000-0002-6640-5428Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Mengyuan LiiD· 2 shared Rongzhen XuiD· 2 shared Xuzhao ZhangiD· 2 shared Ping WangiD· 1 shared Qinyuan Gong· 1 shared Shusen ZhengiD· 1 shared Shuwen ZhengiD· 1 shared Wenbin QianiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Mengyuan LiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 19, 2025

In vivo vaccine generation with a topical small molecule cocktail to eradicates AML and PDAC

Shusen Zheng, Mengyuan Li, Zhaoxing Wu…·Rongzhen Xu

This paper presents a small molecule cocktail-based in vivo vaccine strategy that effectively eradicates AML and PDAC by inducing immunogenic cell death and activating immune responses.

DOI 10.1101/2025.10.19.683274

mouseexperimental assay

ImmunologybioRxivPreprintDec 14, 2024

Natural monoclonal autoantibodies against HERV-K102 Envelope-TM from SLE patients selectively eliminate autoreactive immune cells and cancer cells

Qinyuan Gong, Mengyuan Li, Shuwen Zheng…·Rongzhen Xu

This study identifies monoclonal autoantibodies from SLE patients that target HERV-K102 Env-TM and can eliminate autoreactive immune cells and cancer cells.

1 citation

humanexperimental assay